> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# CBER Plans 21 Guidances This Year
- URL: https://www.fdaweb.com/cber-plans-21-guidances-this-year/
- Published: 2020-02-18T12:00:00.000Z
- Updated: 2026-09-14T16:03:30.000Z
- Author: David McFarland
- Tags: Biologics, #legacy-id-D5146102

CBER has released its Guidance Agenda showing 21 topics the Center is considering for guidance development during calendar year 2020\. The [document](https://www.fda.gov/media/120341/download?ref=fdaweb.com) says the list includes topics that currently have no guidance associated with them, topics where updated guidance may be helpful, and topics for which CBER has already issued Level 1 draft guidances that may be finalized following review of public comments.

There are three categories of guidances in the list: Blood and Blood Components (8 guidances planned); Tissued and Advanced Therapies (10 guidances); and Other (3 guidances).